Clinical Trials Browser

Terminated × Stomach Neoplasms × Sorafenib × Clear all

NCT00595985 2009-07-07

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms